Recombinant Antibody Service Market size was valued at USD 5.2 Billion in 2024 and is forecasted to grow at a CAGR of 8.3% from 2026 to 2033, reaching USD 10.5 Billion by 2033.
The Recombinant Antibody Service Market in South Korea is experiencing significant growth, driven by the increasing demand for personalized medicine and advancements in biotechnology. With a projected compound annual growth rate (CAGR) of 13.8% from 2024 to 2030, the market is expected to reach approximately USD 1,292.4 million by 2030.
Key factors contributing to this growth include:
Monoclonal Antibodies: This segment remains the largest revenue generator, reflecting the industry's focus on targeted therapies.
Contract Manufacturing: The antibodies contract manufacturing market is projected to grow at a CAGR of 9.6% from 2025 to 2030, reaching USD 1,417.9 million by 2030.
Antibody Drug Conjugates: This segment is expected to achieve a CAGR of 12% from 2025 to 2030, with revenues reaching USD 462.5 million by 2030.
Industries driving the demand for recombinant antibody services include:
Pharmaceutical and Biotechnology Companies: These entities are investing heavily in research and development to create innovative therapies.
Academic and Research Institutes: Collaborations with industry players are fostering advancements in antibody research.
Contract Research Organizations (CROs): Providing specialized services to support the development and manufacturing processes.
South Korea's robust infrastructure, including facilities like Samsung Biologics' manufacturing plants, supports this market expansion. The country's strategic focus on biotechnology and favorable regulatory environment further enhance its position as a hub for recombinant antibody services.
As the global demand for targeted therapies continues to rise, South Korea's recombinant antibody service market is poised for sustained growth, offering opportunities for innovation and collaboration across various sectors.
Get an In-Depth Research Analysis of the South Korea Recombinant Antibody Service Market Size And Forecast [2025-2032]
Â
GenScript Biotech Corporation
Abcam plc
Creative Biolabs
Absolute Antibody Ltd.
Thermo Fisher Scientific Inc.
ProteoGenix
Bio-Rad Laboratories
Inc.
Rockland Immunochemicals Inc.
RayBiotech
Inc.
Novoprotein Scientific Inc.
Sino Biological Inc.
Abnova Corporation
ACROBiosystems
Fitzgerald Industries International
Boster Biological Technology Co.
Ltd.
HyTest Ltd.
Randox Laboratories Ltd.
Agilent Technologies
Inc.
AnaSpec
Inc.
Epitomics International Inc.
Cell Signaling Technology
Inc.
OriGene Technologies
Inc.
Meridian Life Science Inc.
Enzo Life Sciences
Inc.
MabPlex Inc.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Recombinant Antibody Service Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Recombinant Antibody Service Market
Monoclonal Antibodies
Polyclonal Antibodies
Bispecific Antibodies
Phage Display
Hybridoma Technology
Transgenic Animal Technology
Single B-cell Technology
Therapeutic Applications
Diagnostic Applications
Research & Development
Pharmaceutical & Biotechnology Companies
Academic & Research Institutions
Contract Research Organizations
Human Source
Mouse Source
Other Animal Sources
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Recombinant Antibody Service Market Research Analysis
1. Introduction of the South Korea Recombinant Antibody Service Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Recombinant Antibody Service Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Recombinant Antibody Service Market, By Type
6. South Korea Recombinant Antibody Service Market, By Application
7. South Korea Recombinant Antibody Service Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Recombinant Antibody Service Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/